YD Bio Stock (NASDAQ:YDES)
Previous Close
$2.27
52W Range
$1.70 - $25.00
50D Avg
$3.39
200D Avg
$8.96
Market Cap
$174.25M
Avg Vol (3M)
$128.78K
Beta
-0.13
Div Yield
-
YDES Company Profile
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.